Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated in Illinois
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Illinois
| Provider | Medicare | Services |
|---|---|---|
| Medstar Laboratory, Inc | $4.17 | 3.7K |
| Springfield Clinic, Llp | $4.18 | 3.0K |
| Chicago Clinical Laboratories, Ltd | $4.18 | 1.7K |
| Star Lab, Inc | $4.18 | 1.6K |
| Optimalab Inc | $4.18 | 1.4K |
| Lifescan Labs Of Illinois, Llc | $4.18 | 1.1K |
| Doctors General Laboratory Corp | $4.18 | 870 |
| Sager, David M.D. | $4.18 | 791 |
| Furmanov, Sergey MD | $4.15 | 680 |
| Simple Laboratories Llc | $4.18 | 547 |
| Stat Laboratory Inc | $4.18 | 529 |
Illinois Pricing in Context
In Illinois, CPT code 85651 (Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated) carries an average Medicare payment of $4.17 — 0% above the national benchmark of $4.17. 122 providers across the state submitted claims for this procedure in 2023, performing 18.9K total services. Individual payments in IL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Illinois is $22.22, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Illinois sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Blood Test procedures, the estimated commercial insurance price in Illinois lands near $8.98, with self-pay cash prices typically around $9.24. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated cost in Illinois?
The average Medicare payment for Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated in Illinois is $4.17, which is 0% above the national average of $4.17. Providers in IL typically bill $22.22 for this procedure.
What does Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated cost with insurance in Illinois?
With commercial insurance in Illinois, Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated costs an estimated $8.98. Without insurance, the estimated cash price is $9.24. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated in Illinois?
122 providers in Illinois billed Medicare for Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated in 2023, performing 18.9K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated cheaper in Illinois than the national average?
No — Red Blood Cell Sedimentation Rate, To Detect Inflammation, Non-Automated costs 0% above the national average in Illinois. The state average Medicare payment is $4.17 compared to $4.17 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.